App to help high school students quit vaping
Vaping Cessation Among Youth: Evaluating the Kick-Nic! App
PHASE2 · Yale University · NCT06662305
This study is testing whether the Kick-Nic! app can help high school students quit vaping better than just using a regular website with quitting resources.
Quick facts
| Phase | PHASE2 |
|---|---|
| Study type | Interventional |
| Enrollment | 306 (estimated) |
| Ages | 13 Years to 19 Years |
| Sex | All |
| Sponsor | Yale University (other) |
| Locations | 1 site (New Haven, Connecticut) |
| Trial ID | NCT06662305 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the Kick-Nic! app in helping high school students quit vaping. Participants will be randomly assigned to either use the app or access a control website with quitting resources. Over an 8-week treatment period, participants will engage with the app or website, with follow-up assessments at 1, 2, 3, and 6 months to measure abstinence rates. The study also includes qualitative interviews to gather feedback on the app's implementation and effectiveness.
Who should consider this trial
Good fit: Ideal candidates are high school students aged 13-19 who are regular e-cigarette users and wish to quit.
Not a fit: Patients with unstable psychiatric conditions or those not currently using nicotine-containing e-cigarettes may not benefit from this study.
Why it matters
Potential benefit: If successful, this app could significantly improve vaping cessation rates among youth.
How similar studies have performed: Other studies have shown promise in using mobile applications for smoking cessation, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. high school aged youth (13-19 years old), 2. regular current (past month) e-cig users using nicotine-containing e-cigs at least 1 day/week. 3. want to quit using e-cigarettes. 4. have a smartphone with data/WIFI plan in order to access and utilize the KickNic! app Exclusion Criteria: * Those who have non-stable (\<2 months) use of anxiolytics, antidepressants, and other psychostimulants or have a history of psychosis or any significant current psychiatric/medical condition that would increase risk will be excluded.
Where this trial is running
New Haven, Connecticut
- Yale University School of Medicine (Connecticut Mental Health Center) — New Haven, Connecticut, United States (RECRUITING)
Study contacts
- Principal investigator: Suchitra Krishnan-Sarin, Ph.D. — Yale University School of Medicine, Dept of Psychiatry
- Study coordinator: Thomas Liss
- Email: thomas.liss@yale.edu
- Phone: 2034447545
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Nicotine Vaping